Results 191 to 200 of about 10,163 (201)

The structure and evolution of FcRn

Research in Immunology, 1996
N E, Simister, J C, Ahouse
openaire   +2 more sources

The efficacy and safety of FcRn inhibitors in patients with myasthenia gravis: a systematic review and meta-analysis

Journal of Neurology
Jiaxuan Li, Xin Wu, Tianchen Chu, Xin Tan, Shixin Wang, Ruisi Qu, Zhouqing Chen, Zhong Wang   +7 more
semanticscholar   +1 more source

Mechanistic incorporation of FcRn binding in plasma and endosomes in a whole body PBPK model for large molecules

Journal of Pharmacokinetics and Pharmacodynamics, 2023
W. E. A. Witte, L. B. Avery, Brian C Mackness, T. Bogaert, Anna Park, M. Sargentini‐Maier   +5 more
semanticscholar   +1 more source

Large-scale hybrid task scheduling in cloud-edge collaborative manufacturing systems with FCRN-assisted random differential evolution

The International Journal of Advanced Manufacturing Technology, 2023
Xiaohan Wang, Lin Zhang, Y. Laili, Yongkui Liu, Feng Li, Zhen Chen, Chun Zhao   +6 more
semanticscholar   +1 more source

A humorális immunválasz diverzitásának és az FcRn fehérje kölcsönhatásainak vizsgálata FcRn transzgenikus állatokban

2023
openaire   +1 more source

Efgartigimod as a novel FcRn inhibitor for autoimmune disease

Neurological Sciences
Yun Yang, Zhengxuan Shen, Fan Shi, Fei Wang, Ning Wen   +4 more
semanticscholar   +1 more source

FcRn

2008
openaire   +1 more source

Tu1660 FcRn Binding and FcRn Mediated Transcytosis by Certolizumab Pegol in Comparison With Other Anti-TNFs

Gastroenterology, 2013
Terry S. Baker, Lara Kevorkian, Andrew Nesbitt   +2 more
openaire   +1 more source

FcRn-Antagonist bei generalisierter Myasthenia gravis

InFo Neurologie + Psychiatrie
Heinz Wiendl, Christian W. Keller
openaire   +1 more source

FcRn and Myasthenia Gravis

openaire   +1 more source